{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:21:55Z","timestamp":1790659315264,"version":"4.1.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministry of Health, Italy","doi-asserted-by":"publisher","award":["GR-2016-02364785"],"award-info":[{"award-number":["GR-2016-02364785"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.jdiacomp.2018.08.012","type":"journal-article","created":{"date-parts":[[2018,8,19]],"date-time":"2018-08-19T10:17:04Z","timestamp":1534673824000},"page":"1076-1084","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Novel epigenetic-sensitive clinical challenges both in type 1 and type 2 diabetes"],"prefix":"10.1016","volume":"32","author":[{"given":"Linda","family":"Sommese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuditta","family":"Benincasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Lanza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Sorriento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concetta","family":"Schiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Lucchese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9606-1232","authenticated-orcid":false,"given":"Roberto","family":"Alfano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni Francesco","family":"Nicoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Napoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0005","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.trsl.2017.05.002","article-title":"Epigenetics and type 1 diabetes: mechanisms and translational applications","volume":"185","author":"Zullo","year":"2017","journal-title":"Transl Res"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0010","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1080\/15592294.2016.1278097","article-title":"Clinical relevance of epigenetics in the onset and management of type 2 diabetes mellitus","volume":"12","author":"Sommese","year":"2017","journal-title":"Epigenetics"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0015","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11892-017-0916-x","article-title":"The role of epigenetics in type 1 diabetes","volume":"17","author":"Jerram","year":"2017","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2014.12.013","article-title":"Epigenetic control of autoimmune diseases: from bench to bedside","volume":"157","author":"Picascia","year":"2015","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0025","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1007\/BF02221682","article-title":"Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland","volume":"35","author":"Kaprio","year":"1992","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0030","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13148-016-0284-4","article-title":"Genome-wide epigenomic profiling for biomarker discovery","volume":"8","author":"Dirks","year":"2016","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0035","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nrg2732","article-title":"Principles and challenges of genomewide DNA methylation analysis","volume":"11","author":"Laird","year":"2010","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004735","article-title":"Genome-wide associations between genetic and epigenetic variation influence mRNA expression and insulin secretion in human pancreatic islets","volume":"10","author":"Olsson","year":"2014","journal-title":"PLoS Genet"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0045","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/bs.ai.2015.04.001","article-title":"HLA-G: an immune checkpoint molecule","volume":"127","author":"Carosella","year":"2015","journal-title":"Adv Immunol"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0050","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.humimm.2016.02.001","article-title":"Association of HLA-G 3\u2032 untranslated region variants with type 1 diabetes mellitus","volume":"77","author":"de Albuquerque","year":"2016","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0055","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/gene.2015.45","article-title":"The association between the HLA-G 14-bp insertion\/deletion polymorphism and type 1 diabetes","volume":"17","author":"Silva","year":"2016","journal-title":"Genes Immun"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0060","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1210\/jc.2009-2747","article-title":"Soluble human leukocyte antigen-g expression and glucose tolerance in subjects with different degrees of adiposity","volume":"95","author":"Solini","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0065","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.dnarep.2015.04.013","article-title":"Epigenetic modifications in DNA could mimic oxidative DNA damage: a double-edged sword","volume":"A32","author":"Ito","year":"2015","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/947a8d4a-3585-4b23-ac84-b47a255a70d9","article-title":"Insulin gene expression is regulated by DNA methylation","volume":"4","author":"Kuroda","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094591","article-title":"Tissue-specific methylation of human insulin gene and PCR assay for monitoring beta cell death","volume":"9","author":"Husseiny","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0080","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.diabres.2011.07.027","article-title":"Abnormal DNA methylation in CD4+ T cells from people with latent autoimmune diabetes in adults","volume":"94","author":"Li","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0085","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrg2540","article-title":"Linking DNA methylation and histone modification: patterns and paradigms","volume":"10","author":"Cedar","year":"2009","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0090","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jaut.2017.11.008","article-title":"Allele-specific methylation of type 1 diabetes susceptibility genes","volume":"89","author":"Kindt","year":"2018","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0095","doi-asserted-by":"crossref","first-page":"13555","DOI":"10.1038\/ncomms13555","article-title":"Increased DNA methylation variability in type 1 diabetes across three immune effector cell types","volume":"7","author":"Paul","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0100","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jaut.2015.12.003","article-title":"Hypomethylation within gene promoter regions and type 1 diabetes in discordant monozygotic twins","volume":"68","author":"Elboudwarej","year":"2016","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0105","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrg2936","article-title":"Gene silencing by microRNAs: contributions of translational repression and mRNA decay","volume":"12","author":"Huntzinger","year":"2011","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0110","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"Micro RNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0115","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.diabres.2018.03.044","article-title":"MicroRNA expression profile in plasma from type 1 diabetic patients: case-control study and bioinformatic analysis","volume":"141","author":"Assmann","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2018.01.022","article-title":"DNA methylation in the pathogenesis of type 2 diabetes in humans","author":"Davegardh","year":"2018","journal-title":"Mol Metab"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0125","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13643-018-0708-7","article-title":"Global and gene-specific DNA methylation in adult type 2 diabetic individuals: a protocol for a systematic review","volume":"7","author":"Mutize","year":"2018","journal-title":"Syst Rev"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0130","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1210\/me.2012-1004","article-title":"Increased DNA methylation and decreased expression of PDX-1 in pancreatic islets from patients with type 2 diabetes","volume":"26","author":"Yang","year":"2012","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0135","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00125-007-0916-5","article-title":"Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion","volume":"51","author":"Ling","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0140","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1471-2350-14-76","article-title":"DNA methylation of the glucagon-like peptide 1 receptor (GLP1R) in human pancreatic islets","volume":"14","author":"Hall","year":"2013","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0145","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.2337\/db16-0996","article-title":"Whole-genome bisulfite sequencing of human pancreatic islets reveals novel differentially methylated regions in type 2 diabetes pathogenesis","volume":"66","author":"Volkov","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0150","doi-asserted-by":"crossref","first-page":"39162","DOI":"10.18632\/oncotarget.10043","article-title":"Inhibition of DNA methyltransferase 1 increases nuclear receptor subfamily 4 group A member 1 expression and decreases blood glucose in type 2 diabetes","volume":"7","author":"Chen","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0155","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12881-018-0542-8","article-title":"Altered DNA methylation in liver and adipose tissues derived from individuals with obesity and type 2 diabetes","volume":"19","author":"Barajas-Olmos","year":"2018","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0160","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3389\/fendo.2018.00132","article-title":"Identification of neuroendocrine stress response-related circulating microRNAs as biomarkers for type 2 diabetes mellitus and insulin resistance","volume":"9","author":"Liang","year":"2018","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0165","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00592-014-0675-y","article-title":"MicroRNA-124a is hyperexpressed in type 2 diabetic human pancreatic islets and negatively regulates insulin secretion","volume":"52","author":"Sebastiani","year":"2015","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0170","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s12015-016-9711-3","article-title":"Possible muscle repair in the human cardiovascular system","volume":"13","author":"Sommese","year":"2017","journal-title":"Stem Cell Rev"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0175","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jjcc.2016.10.004","article-title":"Evidence of epigenetic tags in cardiac fibrosis","volume":"69","author":"Grimaldi","year":"2017","journal-title":"J Cardiol"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0180","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4330\/wjc.v8.i2.211","article-title":"Novel epigenetic-based therapies useful in cardiovascular medicine","volume":"8","author":"Napoli","year":"2016","journal-title":"World J Cardiol"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0185","doi-asserted-by":"crossref","first-page":"137","DOI":"10.15283\/ijsc.2016.9.1.137","article-title":"Severe type 2 diabetes induces reversible modifications of endothelial progenitor cells which are ameliorate by glycemic control","volume":"9","author":"De Pascale","year":"2016","journal-title":"Int J Stem Cells"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0190","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.tips.2015.02.005","article-title":"Epigenetic-related therapeutic challenges in cardiovascular disease","volume":"36","author":"Schiano","year":"2015","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0195","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s11883-010-0156-x","article-title":"Developmental mechanisms involved in the primary prevention of atherosclerosis and cardiovascular disease","volume":"13","author":"Napoli","year":"2011","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0200","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s11883-014-0476-3","article-title":"Epigenetic reprogramming in atherosclerosis","volume":"17","author":"Grimaldi","year":"2015","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0205","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1161\/CIRCULATIONAHA.111.085787","article-title":"Primary prevention of atherosclerosis: a clinical challenge for the reversal of epigenetic mechanisms?","volume":"125","author":"Napoli","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0210","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.atherosclerosis.2010.10.039","article-title":"Endothelial progenitor cells as therapeutic agents in the microcirculation: an update","volume":"215","author":"Napoli","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0215","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/cpf.12210","article-title":"Imaging techniques to evaluate cell therapy in peripheral artery disease: state of the art and clinical trials","volume":"36","author":"Grimaldi","year":"2016","journal-title":"Clin Physiol Funct Imaging"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0220","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jneuroim.2015.10.013","article-title":"Innate and adaptive immune response in stroke: focus on epigenetic regulation","volume":"289","author":"Picascia","year":"2015","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0225","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.2337\/db08-1666","article-title":"Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail","volume":"58","author":"Brasacchio","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0230","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1210\/en.2015-1063","article-title":"The microRNAs in the pathogenesis of metabolic memory","volume":"156","author":"Zhong","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0235","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1182\/blood-2012-01-407106","article-title":"AngiomiR-126 expression and secretion from circulating CD34(+) and CD14(+) PBMCs: role for proangiogenic effects and alterations in type 2diabetics","volume":"121","author":"Mocharla","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0240","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/S0140-6736(13)61576-7","article-title":"The global pandemic of peripheral artery disease","volume":"382","author":"Hirsch","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0245","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1161\/CIRCRESAHA.116.303518","article-title":"The genetic basis of peripheral arterial disease: current knowledge, challenges, and future directions","volume":"116","author":"Kullo","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0250","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1016\/j.jid.2017.08.003","article-title":"MicroRNA-132 with therapeutic potential in chronic wounds","volume":"137","author":"Li","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0255","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.2337\/db15-0863","article-title":"NETosis delays diabetic wound healing in mice and humans","volume":"65","author":"Fadini","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0260","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1161\/ATVBAHA.114.305048","article-title":"Impairment of wound healing in patients with type 2 diabetes mellitus influences circulating microRNA patterns via inflammatory cytokines","volume":"35","author":"Dangwal","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0265","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.2337\/dc10-1303","article-title":"Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments","volume":"33","author":"Tesfaye","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0270","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1440-1681.2011.05497.x","article-title":"Epigenetics: deciphering its role in diabetes and its chronic complications","volume":"38","author":"Villeneuve","year":"2011","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0275","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jdiacomp.2017.10.011","article-title":"Association between a MIR499A polymorphism and diabetic neuropathy in type 2 diabetes","volume":"32","author":"Ciccacci","year":"2018","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0280","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.3892\/mmr.2017.6874","article-title":"MiR-199a-3p is involved in the pathogenesis and progression of diabetic neuropathy through downregulation of serpinE2","volume":"16","author":"Li","year":"2017","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0285","article-title":"Effect of TET2 on the pathogenesis of diabetic nephropathy through activation of transforming growth factor \u03b21 expression via DNA demethylation","author":"Liling","year":"2018","journal-title":"Life Sci"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0290","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.ajpath.2016.12.011","article-title":"High glucose-induced hypomethylation promotes binding of Sp-1 to myoinositol oxygenase: implication in the pathobiology of diabetic tubulopathy","volume":"187","author":"Sharma","year":"2017","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0295","article-title":"Prevalence of diabetic retinopathy in mainland China: a meta-analysis","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0300","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1471-2458-6-58","article-title":"Leading causes of certification for blindness and partial sight in England & Wales","volume":"6","author":"Bunce","year":"2006","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0305","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.visres.2017.02.011","article-title":"Diabetic retinopathy, metabolic memory and epigenetic modifications","volume":"139","author":"Kowluru","year":"2017","journal-title":"Vision Res"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0310","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4239\/wjd.v1.i2.57","article-title":"Neurodegeneration: an early event of diabetic retinopathy","volume":"1","author":"Villarroel","year":"2010","journal-title":"World J Diabetes"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0315","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1167\/iovs.10-6293","article-title":"The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy","volume":"52","author":"Barber","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0320","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.preteyeres.2015.05.001","article-title":"Oxidative stress and epigenetic modifications in the pathogenesis of diabetic retinopathy","volume":"48","author":"Kowluru","year":"2015","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0325","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1167\/iovs.12-10854","article-title":"Epigenetic modification of Sod2 in the development of diabetic retinopathy and in the metabolic memory: role of histone methylation","volume":"54","author":"Zhong","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0330","doi-asserted-by":"crossref","first-page":"5748","DOI":"10.1167\/iovs.16-19759","article-title":"The role of DNA methylation in the metabolic memory phenomenon associated with the continued progression of diabetic retinopathy","volume":"57","author":"Mishra","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0335","doi-asserted-by":"crossref","first-page":"4727942","DOI":"10.1155\/2017\/4727942","article-title":"Differentially expressed microRNAs in the development of early diabetic retinopathy","volume":"2017","author":"Gong","year":"2017","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0340","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/nyas.12757","article-title":"Personalized medicine in diabetes mellitus: current opportunities and future prospects","volume":"1346","author":"Kleinberger","year":"2015","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0345","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.2337\/dc18-S005","article-title":"5. Prevention or delay of type 2 diabetes: standards of medical care in diabetes-2018","volume":"41","author":"American Diabetes Association","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0350","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1530\/JOE-15-0447","article-title":"Current understanding of metformin effect on the control of hyperglycemia in diabetes","volume":"228","author":"An","year":"2016","journal-title":"J Endocrinol"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0355","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1111\/dom.13262","article-title":"Epigenetic effects of metformin: from molecular mechanisms to clinical implications","volume":"20","author":"Bridgeman","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0360","doi-asserted-by":"crossref","first-page":"a019497","DOI":"10.1101\/cshperspect.a019497","article-title":"Epigenetics and human disease","volume":"8","author":"Zoghbi","year":"2016","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0365","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.abb.2010.05.003","article-title":"Regulation of SIRT1 in cellular functions: role of polyphenols","volume":"501","author":"Chung","year":"2010","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0370","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00592-017-1097-4","article-title":"Impact of sirtuin-1 expression on H3K56 acetylation and oxidative stress: a double-blind randomized controlled trial with resveratrol supplementation","volume":"55","author":"Bo","year":"2018","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0375","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.2337\/dc12-0719","article-title":"Effects of metformin versus glipizide on cardiovascular outcomes in patients with type 2 diabetes and coronary artery disease","volume":"36","author":"Hong","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0380","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12933-017-0551-5","article-title":"The addition of vildagliptin to metformin prevents the elevation of interleukin 1\u03b2 in patients with type 2 diabetes and coronary artery disease: a prospective, randomized, open-label study","volume":"16","author":"Younis","year":"2017","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0385","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.4161\/15592294.2014.969617","article-title":"Type 2 diabetes mellitus in relation to global LINE-1 DNA methylation in peripheral blood: a cohort study","volume":"9","author":"Mart\u00edn-N\u00fa\u00f1ez","year":"2014","journal-title":"Epigenetics"},{"key":"10.1016\/j.jdiacomp.2018.08.012_bb0390","first-page":"CR149","article-title":"Global DNA methylation changes in blood of patients with essential hypertension","volume":"16","author":"Smolarek","year":"2010","journal-title":"Med Sci Monit"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872718306330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872718306330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T19:16:20Z","timestamp":1604776580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872718306330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":78,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S1056872718306330"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2018.08.012","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel epigenetic-sensitive clinical challenges both in type 1 and type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2018.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}